Jacobus Pharmaceutical Company, Inc.
483 response sent March 9, 2011 · Princeton, New Jersey
- Inspection
- Jan 24 – Feb 24, 2011
- Investigator
- Atul J. Agrawal
- Pages
- 11
In short: This is Jacobus Pharmaceutical Company, Inc.'s written response to FDA, dated March 9, 2011, for its site in Princeton, New Jersey. It sets out the corrective actions the firm committed to.
Inside this response
This inspection in context
Atul J. Agrawal
5 documents · 2011–2018
Cites 211.192 (production record review) more than any other section. Most of their documents are for sites in New Jersey.
The firmJacobus Pharmaceutical Company, Inc. history
All 2 documents on file for this site, in date order, with what was cited at each inspection.
Similar documentsMore 483 responses
Browse other documents of this type.
Questions about this response
Who inspected Jacobus Pharmaceutical Company, Inc.?
Atul J. Agrawal is named on this 483 response, for the inspection of Jan 24 – Feb 24, 2011. Each investigator has a profile showing what they cite most.
When was Jacobus Pharmaceutical Company, Inc. inspected by FDA?
The inspection ran Jan 24 – Feb 24, 2011, and the 483 response is dated March 9, 2011.
How do I get the full 483 response for Jacobus Pharmaceutical Company, Inc.?
Download the original PDF from FDA Intel for $199, with no subscription. You also get an invoice PDF with the order.